Literature DB >> 23301820

A new botulinum toxin potentially bioequivalent to onabotulinumtoxinA: are there any differences at all?

Gi-Hyeok Yang1, Hyun Ho Jung.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23301820     DOI: 10.1111/dsu.12073

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  5 in total

1.  Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.

Authors:  Han Gil Seo; Nam-Jong Paik; Shi-Uk Lee; Byung-Mo Oh; Min Ho Chun; Bum Sun Kwon; Moon Suk Bang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

2.  Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.

Authors:  Subsai Kongsaengdao; Arkhom Arayawithchanont; Kanoksri Samintharapanya; Pichai Rojanapitayakorn; Benchalak Maneeton; Narong Maneeton
Journal:  Toxins (Basel)       Date:  2021-10-01       Impact factor: 4.546

3.  Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.

Authors:  You Gyoung Yi; Keewon Kim; Youbin Yi; Young-Ah Choi; Ja-Ho Leigh; Moon Suk Bang
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

4.  Comparison of botulinum neurotoxin type A formulations in Asia.

Authors:  Jürgen Frevert; Ki Young Ahn; Mee Young Park; Owen Sunga
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-07-05

5.  Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors:  Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.